Literature DB >> 1915343

Formation of nucleophosmin/B23 oligomers requires both the amino- and the carboxyl-terminal domains of the protein.

Q R Liu1, P K Chan.   

Abstract

Nucleophosmin/B23 is a nucleolar phosphoprotein which forms oligomers. To determine the domain essential for oligomer formation, various deletion and point mutation clones of nucleophosmin/B23 were constructed. Nucleophosmin/B23 and the mutant proteins were produced by (a) coupled in vitro transcription and translation and (b) expression in Escherichia coli with T7 RNA polymerase expression vector (pET-8c). Nucleophosmin/B23 synthesized in vitro has the same peptide map as that synthesized in HeLa cells. Similarly, it formed oligomers which could be detected in SDS/PAGE and were cross-linked with nitrogen mustard in vivo. Substitution of Met5, Met7, and Met9 with Leu or deletion of five amino acids at the C-terminus abolished the oligomerization. Deletion of portions of amino acids in the middle of the molecule (amino acid residues 83-152, 117-186 and 185-240) had little effect on the oligomerization. Co-expression of the N- and C-terminal mutant clones in vitro did not produce oligomers. These results indicate that intra-molecular interactions with both the N- and C-terminal domains are essential for oligomer formation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1915343     DOI: 10.1111/j.1432-1033.1991.tb16236.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  14 in total

1.  Nucleophosmin protein expression level, but not threonine 198 phosphorylation, is essential in growth and proliferation.

Authors:  S N Brady; L B Maggi; C L Winkeler; E A Toso; A S Gwinn; C L Pelletier; J D Weber
Journal:  Oncogene       Date:  2009-06-29       Impact factor: 9.867

2.  Topogenesis of a nucleolar protein: determination of molecular segments directing nucleolar association.

Authors:  R F Zirwes; A P Kouzmenko; J M Peters; W W Franke; M S Schmidt-Zachmann
Journal:  Mol Biol Cell       Date:  1997-02       Impact factor: 4.138

3.  Amino-terminal protein-protein interaction motif (POZ-domain) is responsible for activities of the promyelocytic leukemia zinc finger-retinoic acid receptor-alpha fusion protein.

Authors:  S Dong; J Zhu; A Reid; P Strutt; F Guidez; H J Zhong; Z Y Wang; J Licht; S Waxman; C Chomienne; Z Chen; A Zelent; S J Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

4.  Nucleophosmin and nucleolin regulate K-Ras plasma membrane interactions and MAPK signal transduction.

Authors:  Kerry L Inder; Chiyan Lau; Dorothy Loo; Natasha Chaudhary; Andrew Goodall; Sally Martin; Alun Jones; Dharini van der Hoeven; Robert G Parton; Michelle M Hill; John F Hancock
Journal:  J Biol Chem       Date:  2009-08-06       Impact factor: 5.157

5.  Interactions of the natural product (+)-avrainvillamide with nucleophosmin and exportin-1 Mediate the cellular localization of nucleophosmin and its AML-associated mutants.

Authors:  Herschel Mukherjee; Kok-Ping Chan; Vibeke Andresen; Mariah L Hanley; Bjørn Tore Gjertsen; Andrew G Myers
Journal:  ACS Chem Biol       Date:  2015-01-05       Impact factor: 5.100

6.  Evidence for the ability of nucleophosmin/B23 to bind ATP.

Authors:  J H Chang; J Y Lin; M H Wu; B Y Yung
Journal:  Biochem J       Date:  1998-02-01       Impact factor: 3.857

7.  ARF impedes NPM/B23 shuttling in an Mdm2-sensitive tumor suppressor pathway.

Authors:  Suzanne N Brady; Yue Yu; Leonard B Maggi; Jason D Weber
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

8.  GBPI, a novel gastrointestinal- and brain-specific PP1-inhibitory protein, is activated by PKC and inactivated by PKA.

Authors:  Qing-Rong Liu; Ping-Wu Zhang; Zhicheng Lin; Qi-Fu Li; Amina S Woods; Juan Troncoso; George R Uhl
Journal:  Biochem J       Date:  2004-01-01       Impact factor: 3.857

9.  An IKKα-nucleophosmin axis utilizes inflammatory signaling to promote genome integrity.

Authors:  Xiaojun Xia; Shuang Liu; Zuoxiang Xiao; Feng Zhu; Na-Young Song; Ming Zhou; Bigang Liu; Jianjun Shen; Kunio Nagashima; Timothy D Veenstra; Sandra Burkett; Mahesh Datla; Jami Willette-Brown; Haifa Shen; Yinling Hu
Journal:  Cell Rep       Date:  2013-11-27       Impact factor: 9.423

Review 10.  Anaplastic lymphoma kinase: Role in cancer and therapy perspective.

Authors:  Zhihong Zhao; Vivek Verma; Mutian Zhang
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.